Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 7:52 PM View:  | Matsuda Masaru See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 19-Nov-24 | Sale | 1,775 | $9.68 | $17,190.30 | (< 1%) 183.15K to 181.37K | |
| 19-Nov-24 7:52 PM View: | Matsuda Masaru See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 18-Nov-24 | Grant | 4,875 | -- | -- | 3% 178.27K to 183.15K | |
| 18-Nov-24 7:04 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 15-Nov-24 | Option Exercise | 100 | -- | -- | < 1% 128.67K to 128.77K | |
| 18-Nov-24 7:04 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 15-Nov-24 | Sale | 100 | $10.03 | $1,003.00 | (< 1%) 128.77K to 128.67K | |
| 18-Nov-24 7:04 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Nov-24 | Option Sale | 18,477 | $10.29 | $190,211.00 | (9%) 197.79K to 179.32K | |
| 18-Nov-24 7:04 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Nov-24 | Option Exercise | 18,377 | -- | -- | 10% 179.42K to 197.79K | |
| 18-Nov-24 7:04 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Nov-24 | Sale | 50,649 | $10.29 | $521,406.00 | (28%) 179.32K to 128.67K | |
| 25-Sep-24 9:42 PM View: | Topper David Joseph Chief Financial Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 24-Sep-24 | Sale | 11,626 | $9.48 | $110,264.00 | (7%) 170.0K to 158.37K | |
| 25-Sep-24 9:42 PM View: | Topper David Joseph Chief Financial Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 21-Sep-24 | Grant | 60,000 | -- | -- | 55% 110.0K to 170.0K | |
| 05-Sep-24 5:56 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 03-Sep-24 | Sale (Planned) | 10,000 | $10.77 | $107,695.00 | (5%) 201.94K to 191.94K | |
| 21-Aug-24 4:39 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 19-Aug-24 | Sale | 1,728 | $8.29 | $14,318.20 | (< 1%) 196.59K to 194.86K | |
| 05-Aug-24 4:37 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Aug-24 | Sale (Planned) | 13,206 | $9.02 | $119,106.00 | (6%) 209.79K to 196.59K | |
| 05-Aug-24 4:37 PM View: | Watanabe Todd Franklin See Remarks Director | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Aug-24 | Sale (Planned) | 14,487 | $9.02 | $130,648.00 | (1%) 1.09M to 1.08M | |
| 05-Aug-24 4:37 PM View: | Matsuda Masaru See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 02-Aug-24 | Sale (Planned) | 5,220 | $9.02 | $47,064.00 | (3%) 188.51K to 183.29K | |
| 05-Aug-24 4:37 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Aug-24 | Option Exercise | 6,614 | $1.68 | $11,115.50 | 3% 205.33K to 211.94K | |
| 05-Aug-24 4:37 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Aug-24 | Planned Option Sale | 6,614 | $9.87 | $65,277.50 | (3%) 211.94K to 205.33K | |
| 05-Aug-24 4:37 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Aug-24 | Sale (Planned) | 3,386 | $9.87 | $33,418.50 | (2%) 205.33K to 201.94K | |
| 02-Jul-24 7:13 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Jul-24 | Option Sale | 10,000 | $9.31 | $93,141.00 | (5%) 215.33K to 205.33K | |
| 02-Jul-24 7:13 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Jul-24 | Option Exercise | 10,000 | $1.68 | $16,806.00 | 5% 205.33K to 215.33K | |
| 18-Jun-24 4:51 PM View: | Krishnamohan Neha Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 181% 5.61K to 15.75K | |
| 18-Jun-24 4:52 PM View: | Curran Terrie Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 117% 8.69K to 18.83K | |
| 18-Jun-24 4:51 PM View: | Chaudhuri Bhaskar Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 1% 900.06K to 910.2K | |
| 18-Jun-24 4:52 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 5% 195.19K to 205.33K | |
| 18-Jun-24 4:51 PM View: | Gilbert Halley E Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 117% 8.69K to 18.83K | |
| 18-Jun-24 4:52 PM View: | Heron Patrick J Director 10% Owner | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 117% 8.69K to 18.83K | |
| 18-Jun-24 4:51 PM View: | Lin Sue-Jean Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 113% 8.99K to 19.13K | |
| 18-Jun-24 4:52 PM View: | Leonard Keith R Director | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Jun-24 | Grant | 10,139 | -- | -- | 97% 10.44K to 20.58K | |
| 06-Jun-24 4:15 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Jun-24 | Option Exercise | 10,000 | $1.68 | $16,806.00 | 5% 195.19K to 205.19K | |
| 06-Jun-24 4:15 PM View: | Welgus Howard G. Director | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Jun-24 | Option Sale | 10,000 | $8.01 | $80,091.70 | (5%) 205.19K to 195.19K | |
| 31-May-24 4:50 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 30-May-24 | Option Exercise | 23,000 | -- | -- | 11% 209.79K to 232.79K | |
| 31-May-24 4:50 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 30-May-24 | Sale | 23,000 | $8.75 | $201,319.00 | (10%) 232.79K to 209.79K | |
| 31-May-24 4:50 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 29-May-24 | Option Sale | 23,000 | $8.72 | $200,470.00 | (9%) 259.75K to 236.75K | |
| 31-May-24 4:50 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 29-May-24 | Sale | 26,952 | $8.72 | $234,916.00 | (11%) 236.75K to 209.79K | |
| 29-May-24 7:38 PM View: | Matsuda Masaru See Remark | Arcutis Biotherapeutics, Inc. (ARQT) | 28-May-24 | Sale | 1,775 | $9.01 | $15,988.10 | (< 1%) 190.28K to 188.51K | |
| 29-May-24 7:38 PM View: | Matsuda Masaru See Remark | Arcutis Biotherapeutics, Inc. (ARQT) | 27-May-24 | Grant | 4,875 | -- | -- | 3% 185.41K to 190.28K | |
| 20-May-24 5:12 PM View: | Edwards Larry Todd SVP Chief Commercial Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 17-May-24 | Sale | 7,640 | $8.98 | $68,582.00 | (5%) 148.0K to 140.36K | |
| 20-May-24 5:12 PM View: | Edwards Larry Todd SVP Chief Commercial Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 16-May-24 | Grant | 60,000 | -- | -- | 68% 88.0K to 148.0K | |
| 03-May-24 4:22 PM View: | Matsuda Masaru See Remark | Arcutis Biotherapeutics, Inc. (ARQT) | 02-May-24 | Sale (Planned) | 5,016 | $8.74 | $43,828.80 | (3%) 190.42K to 185.41K | |
| 03-May-24 4:22 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 02-May-24 | Sale (Planned) | 9,555 | $8.74 | $83,489.70 | (4%) 269.3K to 259.75K | |
| 03-May-24 4:29 PM View: | Moore Matthew Richard SVP and Chief Business Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 02-May-24 | Sale | 4,681 | $8.74 | $40,901.60 | (3%) 150.19K to 145.5K | |
| 03-May-24 4:22 PM View: | Watanabe Todd Franklin See Remarks Director | Arcutis Biotherapeutics, Inc. (ARQT) | 02-May-24 | Sale (Planned) | 13,783 | $8.74 | $120,433.00 | (1%) 1.11M to 1.09M | |
| 03-May-24 4:29 PM View: | Moore Matthew Richard SVP and Chief Business Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 01-May-24 | Grant | 4,166 | -- | -- | 3% 146.02K to 150.19K | |
| 11-Apr-24 8:32 PM View: | Topper David Joseph Chief Financial Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Apr-24 | Grant | 110,000 | -- | -- | 100% 0 to 110.0K | |
| 06-Mar-24 10:00 PM View: | Matsuda Masaru See Remark | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-24 | Sale (Planned) | 3,760 | $11.12 | $41,815.70 | (2%) 194.18K to 190.42K | |
| 06-Mar-24 5:12 PM View: | Burnett Patrick See Remarks | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-24 | Sale (Planned) | 4,782 | $11.12 | $53,181.60 | (2%) 274.08K to 269.3K | |
| 06-Mar-24 10:00 PM View: | Moore Matthew Richard SVP and Chief Business Officer | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-24 | Sale (Planned) | 3,468 | $11.12 | $38,568.30 | (2%) 149.49K to 146.02K | |
| 06-Mar-24 5:09 PM View: | Watanabe Todd Franklin See Remarks Director | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-24 | Sale (Planned) | 14,903 | $11.12 | $165,739.00 | (1%) 1.12M to 1.11M | |
| 06-Mar-24 4:28 PM View: | Heron Patrick J Director | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-24 | Private Purchase | 21,052 | $9.50 | $199,994.00 | < 1% 8.8M to 8.82M | |
| 01-Mar-24 4:11 PM View: | Watanabe Todd Franklin See Remarks Director | Arcutis Biotherapeutics, Inc. (ARQT) | 28-Feb-24 | Sale (Planned) | 2,465 | $10.60 | $26,129.00 | (< 1%) 1.12M to 1.12M | |
| 15-Feb-24 6:32 PM View: | Matsuda Masaru See Remark | Arcutis Biotherapeutics, Inc. (ARQT) | 13-Feb-24 | Grant | 119,550 | -- | -- | 160% 74.63K to 194.18K |
